.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Boehringer Ingelheim
Fuji
Chinese Patent Office
Argus Health
Johnson and Johnson
Express Scripts
Medtronic
Daiichi Sankyo
Baxter

Generated: September 20, 2017

DrugPatentWatch Database Preview

HYTRIN Drug Profile

« Back to Dashboard

What is the patent landscape for Hytrin, and what generic Hytrin alternatives are available?

Hytrin is a drug marketed by Abbott and is included in two NDAs.

The generic ingredient in HYTRIN is terazosin hydrochloride. There are twenty-four drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the terazosin hydrochloride profile page.

Summary for Tradename: HYTRIN

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list33
Clinical Trials: see list2
Patent Applications: see list736
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:HYTRIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-001Dec 14, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
TABLET;ORAL019057-003Aug 7, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-004Dec 14, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
TABLET;ORAL019057-004Aug 7, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-002Dec 14, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
CAPSULE;ORAL020347-003Dec 14, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
TABLET;ORAL019057-002Aug 7, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
HYTRIN
terazosin hydrochloride
TABLET;ORAL019057-001Aug 7, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: HYTRIN

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Johnson and Johnson
Fish and Richardson
Merck
Deloitte
McKinsey
Daiichi Sankyo
Harvard Business School
Farmers Insurance
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot